Article
Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
Mutation research - 3 Feb 2010
Yadav Sunishtha S, Ruwali Munindra, Pant Mohan C, Shukla Pragya, Singh Ram L, Parmar Devendra
Abstract excerpt
The present case-control study attempted to investigate the association of poor metabolizer (PM) genotypes of cytochrome P450 2D6 (CYP2D6*4 and CYP2D6*10) with squamous cell carcinoma of head and neck (HNSCC) and treatment response in patients receiving chemotherapy or combination of chemo- and radiotherapy. Cases with the PM genotypes of CYP2D6 displayed a significantly increased risk for HNSCC as compared to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.